TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35217670

Group type: COMPARATOR
Intervention: albendazole
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: albendazole and ivermectin combination therapy
Number of subjects: 80
Study: 34847060

Group type: EXPERIMENTAL
Intervention: 8-week mobile device-based resilience training program
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (8-week program of placebo information)
Number of subjects: 103
Study: 34903116

Group type: EXPERIMENTAL
Intervention: Fluoridated milk (F-milk) adjunctive to 1000-ppm fluoride dentifrice (FD)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Non-fluoridated milk (non-F-milk) adjunctive to 1000-ppm fluoride dentifrice (FD)
Number of subjects: 7

Group type: COMPARATOR
Intervention: 1000-ppm fluoride dentifrice (FD) alone
Number of subjects: 7
Study: 32597390

Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) intervention; patient-selected relaxing 3D videos projected during TAVI
Number of subjects: 32
Study: 36103212

Group type: EXPERIMENTAL
Intervention: High dosing grape seed flour (GSF ≈ 1 g/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Starch (placebo)
Number of subjects: 30
Study: 34088883

Group type: EXPERIMENTAL
Intervention: RPE of 9, 1, 4, or 8 minutes
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RPE of 13, 1, 4, or 8 minutes
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RPE of 17, 1, 4, or 8 minutes
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Increased RPEs (9, 13, 17)
Number of subjects: 20
Study: 32428066

Group type: EXPERIMENTAL
Intervention: Interdisciplinary intervention with motivational approach
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control - traditional approach aiming at lifestyle modifications
Number of subjects: 37
Study: 34575371

Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 32432319

Group type: EXPERIMENTAL
Intervention: Instrumental variable (IV) analysis using bed availability in the intensive care unit as an instrument for admission to the intensive care unit.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparison of IV balance or bias with the balance or bias that would have been produced under randomization.
Number of subjects: 0
Study: 35916524

Group type: EXPERIMENTAL
Intervention: Piperacillin-Tazobactam (TZP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Carbapenems
Number of subjects: 40
Study: 34256159

Group type: EXPERIMENTAL
Intervention: Higher level of caregiver mastery
Number of subjects: 170
Study: 32232481

Group type: EXPERIMENTAL
Intervention: Interim PET (i-PET) with ΔSUV ≥66%
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: ΔSUV as a continuous variable
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Visual 5-point scale (5-PS) on i-PET
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: ΔSUV ≥66%
Number of subjects: 158
Study: 35356064

Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 152
Study: 33720783

Group type: EXPERIMENTAL
Intervention: ViperaTAb antivenom
Number of subjects: 170
Study: 35610532

Group type: EXPERIMENTAL
Intervention: Long-term methimazole (LT‐MMI)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Radioactive iodine (RAI)
Number of subjects: 64
Study: 32959604

Group type: EXPERIMENTAL
Intervention: TB treatment under BRAC program
Number of subjects: 900
Study: 33547300

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus standard care
Number of subjects: 26
Study: 33023492

Group type: EXPERIMENTAL
Intervention: Intervention group (17 facilities)
Number of subjects: 3400

Group type: COMPARATOR
Intervention: Control group (24 facilities)
Number of subjects: 3400
Study: 35637847

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex) in groups B and C
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control group D (no Dex)
Number of subjects: 184
Study: 33096207

Group type: EXPERIMENTAL
Intervention: Pooling strategies with pools of 5, 10, 20, or 50 samples
Number of subjects: 150
Study: 32212418

Group type: EXPERIMENTAL
Intervention: IV relebactam 1150 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral moxifloxacin 400 mg (positive control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: IV placebo
Number of subjects: 0
Study: 34823416

Group type: EXPERIMENTAL
Intervention: FIFA 11+ Kids programme (FT, n = 12)
Number of subjects: 24
Study: 33611898

Group type: EXPERIMENTAL
Intervention: Firesorb bioresorbable scaffold (BRS) implantation
Number of subjects: 45
Study: 32554183

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) administration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls (no intervention)
Number of subjects: 20
Study: 32846465

Group type: EXPERIMENTAL
Intervention: Open-label RCTs
Number of subjects: 110

Group type: COMPARATOR
Intervention: Blinded RCTs
Number of subjects: 110
Study: 33561904

Group type: COMPARATOR
Intervention: Control virgin olive oil (VOO)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Virgin olive oil enriched with its own phenolic compounds (FVOO)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Virgin olive oil enriched with additional phenolic compounds from thyme (FVOOT)
Number of subjects: 33
Study: 32581088

Group type: EXPERIMENTAL
Intervention: Rituximab (4×375 mg/m2) and glucocorticoids (higher or lower dose regimen, reducing from either 1 mg/kg/day or 0.5 mg/kg/day to 10 mg/day by 4 months)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Rituximab and glucocorticoids
Number of subjects: 188
Study: 35340062

Group type: EXPERIMENTAL
Intervention: Denosumab every 6 months
Number of subjects: 110

Group type: COMPARATOR
Intervention: Risedronate daily
Number of subjects: 110
Study: 34309006

Group type: EXPERIMENTAL
Intervention: Continuous EEG (cEEG)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Repeated routine EEG (rEEG)
Number of subjects: 364
Study: 32052026

Group type: EXPERIMENTAL
Intervention: Bifenthrin barrier spray and larval habitat management (LHM)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Larval habitat management (LHM) alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bifenthrin barrier spray alone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Yards neighboring treated yards
Number of subjects: 16
Study: 34037578

Group type: EXPERIMENTAL
Intervention: Use of medicinal plants at home
Number of subjects: 376

Group type: COMPARATOR
Intervention: Use of traditional remedies for fever control
Number of subjects: 376

Group type: COMPARATOR
Intervention: Use of traditional remedies for common cold management
Number of subjects: 376

Group type: COMPARATOR
Intervention: Following traditional care during a common cold
Number of subjects: 376

Group type: COMPARATOR
Intervention: Growing medicinal plants at home
Number of subjects: 376

Group type: COMPARATOR
Intervention: Using medicinal plants for health purposes in the household
Number of subjects: 376
Study: 35763097

Group type: EXPERIMENTAL
Intervention: Standard prophylactic intravenous hydration
Number of subjects: 0

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 0
Study: 33283757

Group type: EXPERIMENTAL
Intervention: RDI ≥30 episodes/h
Number of subjects: 265

Group type: COMPARATOR
Intervention: RDI <30 episodes/h
Number of subjects: 265
Study: 32506278

Group type: EXPERIMENTAL
Intervention: Systemic erythropoietin (10,000 units twice a day for 3 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral steroids (prednisone 75 mg daily tapered off in 6 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systemic erythropoietin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral steroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35172029

Group type: EXPERIMENTAL
Intervention: Platelet rich fibrin matrix (PRFM)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Peripheral blood mesenchymal stem cells (PBMSCs) embedded in PRFM
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Platelet rich fibrin matrix (PRFM) with PBMSCs
Number of subjects: 15
Study: 34109595

Group type: EXPERIMENTAL
Intervention: Patients with NSCLC and COVID-19
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: NLR >8.35
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: PLR >29.14
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: NLR and PLR
Number of subjects: 342

Group type: COMPARATOR
Intervention: Age-matched controls without COVID-19
Number of subjects: 342
Study: 33003591

Group type: EXPERIMENTAL
Intervention: 10-min thermotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20-min thermotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 36050629

Group type: EXPERIMENTAL
Intervention: US-guided internal superior laryngeal nerve block with 2 ml of 0.25% ropivacaine bilaterally immediately after operation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental group (US-guided iSLN block)
Number of subjects: 0
Study: 34182375

Group type: EXPERIMENTAL
Intervention: Conventional wine
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Natural wine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo-controlled group (dealcoholized wine)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (BAC = 0 g/l)
Number of subjects: 44
Study: 35497374

Group type: EXPERIMENTAL
Intervention: Digital COPD education program (accessible for three months)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no digital COPD education program)
Number of subjects: 37
Study: 32556658

Group type: EXPERIMENTAL
Intervention: Conventional endodontic access
Number of subjects: 20

Group type: COMPARATOR
Intervention: Minimally invasive endodontic access
Number of subjects: 20
Study: 32666428

Group type: EXPERIMENTAL
Intervention: Antegrade approach (AGA)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Retrograde approach (RGA)
Number of subjects: 217
Study: 33582875

Group type: EXPERIMENTAL
Intervention: Smart Pilot View (SPV)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 34
Study: 34213683

Group type: EXPERIMENTAL
Intervention: SPP (15 cm H2O) with FBS
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: SPP (15 cm H2O) with DW
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (0 cm H2O)
Number of subjects: 72
Study: 32889266

Group type: EXPERIMENTAL
Intervention: High CaCO3 content
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low groundwater table levels
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High shrub cover
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Groundwater table level, canopy cover, and proportion of damaged trees
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Deer browsing
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Soil properties (pH, CaCO3 content)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ash dieback
Number of subjects: 32
Study: 33318373

Group type: EXPERIMENTAL
Intervention: 10-kHz High-frequency Therapy (HF10 Therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional low-frequency SCS
Number of subjects: 0
Study: 35298314

Group type: EXPERIMENTAL
Intervention: PA + anodal tDCS
Number of subjects: 28

Group type: COMPARATOR
Intervention: PA + sham tDCS
Number of subjects: 28
Study: 32885341

Group type: EXPERIMENTAL
Intervention: SRP followed by laser therapy of the periodontal pockets with 980 nm diode laser, 1 W, continuous wave mode, 20 s per tooth side, repeated twice at 5–7 day intervals.
Number of subjects: 36

Group type: COMPARATOR
Intervention: SRP (scaling, root planing and polishing)
Number of subjects: 36
Study: 32960886

Group type: EXPERIMENTAL
Intervention: Telephone-based health coaching (TBHC)
Number of subjects: 4283

Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 4283
Study: 36129713

Group type: EXPERIMENTAL
Intervention: SAVE (6-week automated interactive text message program)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control (attention control group)
Number of subjects: 218
Study: 34105614

Group type: EXPERIMENTAL
Intervention: Orofacial myofunctional therapy associated with photobiomodulation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Orofacial myofunctional therapy associated with inactive photobiomodulation (placebo)
Number of subjects: 11
Study: 33082420

Group type: EXPERIMENTAL
Intervention: Hypothermic oxygenated machine perfusion (HOPE)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional-cold-storage (CCS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: HOPE
Number of subjects: 15

Group type: COMPARATOR
Intervention: CCS
Number of subjects: 15
Study: 35954510

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control
Number of subjects: 22
Study: 33653805

Group type: EXPERIMENTAL
Intervention: High-dose prenatal vitamin D3 supplementation
Number of subjects: 1176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1176
Study: 33075157

Group type: EXPERIMENTAL
Intervention: FamTechCare telehealth intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard telephone support
Number of subjects: 68
Study: 32239190

Group type: EXPERIMENTAL
Intervention: Dorzolamide-timolol
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (artificial tears)
Number of subjects: 63
Study: 35843287

Group type: COMPARATOR
Intervention: Clear fluids only for 18 hours before CE and simethicone 200 mg in 150 mL water immediately before CE (Arm A)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Clear fluids only for 18 hours before CE and simethicone 200 mg in 150 mL water immediately before CE + 2 L of polyethylene glycol (PEG) 12 hours before CE (Arm B)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Clear fluids only for 18 hours before CE and simethicone 200 mg in 150 mL water immediately before CE + 1 L PEG + sodium ascorbate 3 hours before CE (Arm C)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Overall SBVQ across the 3 arms
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Distal SBVQ across the 3 arms
Number of subjects: 229

Group type: COMPARATOR
Intervention: Tolerability in Arm A
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Tolerability in Arm B
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Tolerability in Arm C
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Comparison of tolerability between Arm A and Arms B and C
Number of subjects: 229
Study: 32618857

Group type: EXPERIMENTAL
Intervention: Shoe lift under the nonaffected leg with balance training (shoe insert group, n = 18)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Balance training alone (control group, n = 18)
Number of subjects: 36
Study: 32113756

Group type: EXPERIMENTAL
Intervention: Calcium propionate supplementation (5% dry matter)
Number of subjects: 24
Study: 33006767

Group type: COMPARATOR
Intervention: Topical corticosteroid (TCS) - mometasone furoate 0.1% ointment + dummy NB‐UVB
Number of subjects: 517

Group type: COMPARATOR
Intervention: Narrowband UVB (NB‐UVB) - NB‐UVB + placebo TCS
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Combination treatment - TCS + NB‐UVB
Number of subjects: 517
Study: 32213509

Group type: EXPERIMENTAL
Intervention: Manual acupuncture (20 sessions at true acupuncture points plus usual care)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sham acupuncture (20 sessions at heterosegmental non-acupuncture points plus usual care)
Number of subjects: 150
Study: 36311789

Group type: EXPERIMENTAL
Intervention: ECM‐associated mRNA‐lncRNA‐based prognostic panel (ECM‐APP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster 2 (best prognosis)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-risk population (unfavorable prognosis)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-risk population (favorable prognosis)
Number of subjects: 0
Study: 34401368

Group type: EXPERIMENTAL
Intervention: internet-delivered cognitive behavioral therapy for insomnia (iCBT-i)
Number of subjects: 21

Group type: COMPARATOR
Intervention: active control group
Number of subjects: 21
Study: 32858844

Group type: EXPERIMENTAL
Intervention: Probiotic intake for 4 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 36028858

Group type: EXPERIMENTAL
Intervention: Givosiran (2.5 mg/kg monthly)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 33252870

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 1154

Group type: COMPARATOR
Intervention: Face-mask ventilation
Number of subjects: 1154
Study: 36167599

Group type: EXPERIMENTAL
Intervention: Degarelix (240-80-80 mg) + Apalutamide (240 mg/d) for 3 months
Number of subjects: 89

Group type: COMPARATOR
Intervention: Degarelix + Matching Placebo for 3 months
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Degarelix + Apalutamide
Number of subjects: 89
Study: 33958669

Group type: EXPERIMENTAL
Intervention: Intracorporeal anastomosis (IA)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Extracorporeal anastomosis (EA)
Number of subjects: 59
Study: 36402355

Group type: EXPERIMENTAL
Intervention: Tight control (140/90 mmHg)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Liberal control (150/95 mmHg)
Number of subjects: 256
Study: 32091602

Group type: EXPERIMENTAL
Intervention: SAM Extremity Tourniquet (SAM-XT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CAT Generation 7 (CAT7)
Number of subjects: 60

Group type: COMPARATOR
Intervention: SOF Tactical Tourniquet Wide (SOFTT-W)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Comparison of slack between CAT7 and SAM-XT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Correlation between slack and hemorrhage control rate
Number of subjects: 60
Study: 33729046

Group type: EXPERIMENTAL
Intervention: High bullying victimization and perpetration class (fifth graders)
Number of subjects: 4058

Group type: EXPERIMENTAL
Intervention: High bullying victimization class (fifth graders)
Number of subjects: 4058

Group type: EXPERIMENTAL
Intervention: Seventh-grade students
Number of subjects: 4058
Study: 33764567

Group type: EXPERIMENTAL
Intervention: Dolutegravir (DTG)
Number of subjects: 39
Study: 35644332

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study: 33764461

Group type: EXPERIMENTAL
Intervention: TEXT4myBACK intervention (4 semi-personalized text messages per week for 12 weeks)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Control group (1 text message with a link to LBP and diet online information package)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: TEXT4myBACK intervention
Number of subjects: 304

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 304
Study: 33220737

Group type: EXPERIMENTAL
Intervention: Oxygenated hypothermic machine perfusion (HMPO2)
Number of subjects: 197

Group type: COMPARATOR
Intervention: HMP without oxygenation (HMP)
Number of subjects: 197
Study: 33200382

Group type: EXPERIMENTAL
Intervention: Extrinsic message (Easy Extrinsic, Hard Extrinsic)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Strength training workout with motivational message
Number of subjects: 308
Study: 36086748

Group type: EXPERIMENTAL
Intervention: Telmisartan-statin group (n=48)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Amlodipine-statin group (n=51)
Number of subjects: 99
Study: 33938653

Group type: EXPERIMENTAL
Intervention: anterior QLB (n=25) with preoperative ropivacaine 3.75 mg/mL, 20 mL bilaterally
Number of subjects: 70

Group type: COMPARATOR
Intervention: placebo QLB (n=22) with preoperative isotonic saline, 20 mL bilaterally
Number of subjects: 70

Group type: COMPARATOR
Intervention: controls (n=23) given only standard intravenous and oral analgesia
Number of subjects: 70
Study: 616774593

Group type: EXPERIMENTAL
Intervention: PDCA cycle based nursing care
Number of subjects: 86

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 86
Study: 34895364

Group type: EXPERIMENTAL
Intervention: Lacrimal and double nasal mucosal flaps
Number of subjects: 90

Group type: COMPARATOR
Intervention: Endoscopic dacryocystorhinostomy without flap preservation
Number of subjects: 90
Study: 32222762

Group type: EXPERIMENTAL
Intervention: HTF culture medium
Number of subjects: 97

Group type: COMPARATOR
Intervention: G5 culture medium
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: IVF placenta
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: G5 placenta
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: HTF placenta
Number of subjects: 97
Study: 35704475

Group type: EXPERIMENTAL
Intervention: ASC-enriched fat grafting (10 × 10^6 ASCs/mL fat graft)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo-enriched fat grafting
Number of subjects: 10
Study: 32690103

Group type: EXPERIMENTAL
Intervention: Deep learning auto-segmentation (DLAS)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Atlas-based auto-segmentation (ABAS)
Number of subjects: 56
Study: 33408315

Group type: EXPERIMENTAL
Intervention: 10 mg rosuvastatin once daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: 2.5 mg rosuvastatin once daily
Number of subjects: 120
Study: 33715955

Group type: EXPERIMENTAL
Intervention: Regular coffee (80 mL)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Decaffeinated coffee (80 mL, placebo)
Number of subjects: 156
Study: 32787879

Group type: EXPERIMENTAL
Intervention: n-3PUFA supplementation (3.3 g/day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Corn oil placebo (PLA) (3.0 g/day)
Number of subjects: 27
Study: 35485000

Group type: EXPERIMENTAL
Intervention: VR helmets
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control (traditional behavior guidance procedures)
Number of subjects: 128
Study: 33849118

Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage under fiberoptic bronchoscopy
Number of subjects: 148

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 148
Study: 34355611

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (LDX)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 20
Study: 32424499

Group type: EXPERIMENTAL
Intervention: Brace and physiotherapy group (Group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Brace treatment only group (Group 1)
Number of subjects: 30